Quarterly report · Q2
6951.TEDINET S100O9I5
Period2021-04-01 → 2021-09-30
Filed2022-06-16
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Amends S100MQ4F.
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥53.4bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Revenue | ¥110.4bn | 2020-04-01 → 2021-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥49.4bn | 2020-04-01 → 2020-09-30 | Cons. | Net sales |
| Operating income | ¥3.7bn | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Operating income | ¥2.5bn | 2020-04-01 → 2020-09-30 | Cons. | Operating income |
| Ordinary income | ¥4.7bn | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥6.5bn | 2020-04-01 → 2021-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.9bn | 2020-04-01 → 2020-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥4.8bn | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥2.9bn | 2020-04-01 → 2020-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥3.7bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥3.7bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.9bn | 2020-04-01 → 2020-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥3.7bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Net income | ¥1.9bn | 2020-04-01 → 2020-09-30 | Cons. | Profit loss |
| Total assets | ¥168.3bn | at 2021-09-30 | Cons. | Assets |
| Total assets | ¥146.4bn | at 2021-03-31 | Cons. | Assets |
| Total assets | ¥136.7bn | at 2020-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥90.9bn | at 2021-09-30 | Cons. | Liabilities |
| Total liabilities | ¥95.4bn | at 2021-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥77.4bn | at 2021-09-30 | Cons. | Net assets |
| Net assets / equity | ¥51.0bn | at 2021-03-31 | Cons. | Net assets |
| Net assets / equity | ¥46.9bn | at 2020-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥31.9bn | at 2021-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥15.4bn | at 2021-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥30.2bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.5bn | at 2021-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.1bn | at 2020-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.0bn | at 2020-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥5.4bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.4bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥662m | 2020-04-01 → 2020-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥438m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥7.0bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥5.7bn | 2020-04-01 → 2020-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥11.3bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥3.3bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥3.1bn | 2020-04-01 → 2020-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥75.56 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥59.59 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥77.51 | 2020-04-01 → 2021-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥40 | 2020-04-01 → 2020-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥37.6 | 2020-07-01 → 2020-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 46.0% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.8% | at 2021-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.3% | at 2020-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-09-30 | −¥2.3bn |
| jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥14.5bn |
| jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥14.5bn |
| jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥5.8bn |
| jpcrp040300-q2r_E01905-000Medical Equipmentreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥9.4bn |
| jpcrp040300-q2r_E01905-000Medical Equipmentreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥9.4bn |
| jpcrp040300-q2r_E01905-000Medical Equipmentreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥820m |
| jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥29.5bn |
| jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥29.5bn |
| jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | −¥670m |
| —segment total | revenue | 2021-04-01 → 2021-09-30 | ¥53.4bn |
| —segment total | revenue external | 2021-04-01 → 2021-09-30 | ¥53.4bn |
| —segment total | segment profit | 2021-04-01 → 2021-09-30 | ¥6.0bn |
| Reconciling Itemsreconciling | segment profit | 2020-04-01 → 2020-09-30 | −¥2.0bn |
| jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segment | revenue | 2020-04-01 → 2020-09-30 | ¥12.0bn |
| jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segment | revenue external | 2020-04-01 → 2020-09-30 | ¥12.0bn |
| jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segment | segment profit | 2020-04-01 → 2020-09-30 | ¥4.1bn |
| jpcrp040300-q2r_E01905-000Medical Equipmentreportable segment | revenue | 2020-04-01 → 2020-09-30 | ¥7.3bn |
| jpcrp040300-q2r_E01905-000Medical Equipmentreportable segment | revenue external | 2020-04-01 → 2020-09-30 | ¥7.3bn |
| jpcrp040300-q2r_E01905-000Medical Equipmentreportable segment | segment profit | 2020-04-01 → 2020-09-30 | ¥737m |
| jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segment | revenue | 2020-04-01 → 2020-09-30 | ¥30.1bn |
| jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segment | revenue external | 2020-04-01 → 2020-09-30 | ¥30.1bn |
| jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segment | segment profit | 2020-04-01 → 2020-09-30 | −¥288m |
| —segment total | revenue | 2020-04-01 → 2020-09-30 | ¥49.4bn |
| —segment total | revenue external | 2020-04-01 → 2020-09-30 | ¥49.4bn |
| —segment total | segment profit | 2020-04-01 → 2020-09-30 | ¥4.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 542
| Item | Context | Value | Unit |
|---|---|---|---|
| Repayment of long term loans payable fin cf | Prior1YTDDuration | -2040000000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | -3374000000 | JPY |
| Redemption of bonds fin cf | Prior1YTDDuration | -1693000000 | JPY |
| Redemption of bonds fin cf | CurrentYTDDuration | -2643000000 | JPY |
| Proceeds from issuance of common stock fin cf | Prior1YTDDuration | － | JPY |
| Proceeds from issuance of common stock fin cf | CurrentYTDDuration | 22599000000 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -584000000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -584000000 | JPY |
| Other net fin cf | Prior1YTDDuration | -144000000 | JPY |
| Other net fin cf | CurrentYTDDuration | -181000000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | 3097000000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | 11279000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | 29000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | -17000000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | -1896000000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | 16257000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 14032000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 14481000000 | JPY |
| Netincreasedecreaseincashandcashequivalentsfromaccountingtermalterationsofsubsidiaries | Prior1YTDDuration | － | JPY |
| Netincreasedecreaseincashandcashequivalentsfromaccountingtermalterationsofsubsidiaries | CurrentYTDDuration | -539000000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 12135000000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 30200000000 | JPY |
| Salaries and allowances sga | Prior1YTDDuration | 5706000000 | JPY |
| Salaries and allowances sga | CurrentYTDDuration | 5811000000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 405000000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 398000000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 235000000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 241000000 | JPY |
| Provision for directors retirement benefits sga | Prior1YTDDuration | 6000000 | JPY |
| Provision for directors retirement benefits sga | CurrentYTDDuration | 6000000 | JPY |
| Provision for share based remuneration for directors and other officers sga | Prior1YTDDuration | 43000000 | JPY |
| Provision for share based remuneration for directors and other officers sga | CurrentYTDDuration | 44000000 | JPY |
| Depreciation sga | Prior1YTDDuration | 614000000 | JPY |
| Depreciation sga | CurrentYTDDuration | 699000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E01905-000ScientificAndMeasurementInstrumentsReportableSegmentsMember | 30109000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E01905-000IndustrialEquipmentReportableSegmentsMember | 12025000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E01905-000MedicalEquipmentReportableSegmentsMember | 7253000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 49388000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 49388000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E01905-000ScientificAndMeasurementInstrumentsReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E01905-000IndustrialEquipmentReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E01905-000MedicalEquipmentReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E01905-000ScientificAndMeasurementInstrumentsReportableSegmentsMember | 30109000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E01905-000IndustrialEquipmentReportableSegmentsMember | 12025000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E01905-000MedicalEquipmentReportableSegmentsMember | 7253000000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 49388000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |